José Castillo

CTO Univercells Group

As founder and CTO, José is the architect of highly efficient production processes that will make biologics available and affordable for all. The goal is to disrupt the industry and become the leader of comprehensive manufacturing solutions.
 
A recognized technology leader in the biopharmaceutical industry, José brings a strong track record in innovative processes design and successful commercialization.
Previous accomplishments include the start-up of Artelis, where he designed and developed bioreactors that transformed industrial operations – the iCellis system being now considered as standard in the vaccines and gene therapy industry. The technology was industrialized at ATMI LifeSciences and Pall Lifesciences, where José held the position of Cell Culture Technologies Director. Prior to Artelis, José was Head of Viral Vaccine Industrialization at GSK Vaccines.
 
With a background in Chemical Engineering, Jose’s education includes a PhD in Applied Sciences from the Université Libre de Bruxelles, and an entrepreneurship degree from the Solvay Business School.

Viral Vectored Gene therapies approved worldwide